menu
    • menu

    Company profile for Navamedic

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Navamedic is a Nordic pharmaceutical company committed to improving people's quality of life by supplying high-quality prescription, consumer health, and hospital products to pharmacies and hospitals. Our expanding portfolio addresses prevalent public health issues like obesity, Parkinson’s disease, and gastrointestinal ailments, empowering individuals to lead healthier and more fulfilling lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NavamedicNorway Flag
    Country
    Country
    Norway
    Address
    Address
    Henrik Ibsensgate 100 0255 Oslo
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://navamedic.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navamedic ASA: Double Digit Growth In The 3Rd Quarter, 2025
    Navamedic ASA: Double Digit Growth In The 3Rd Quarter, 2025

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa-double-digit-growth-in-the-3rd-quarter-2025-302596271.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Navamedic Asa Reports Financials for 2nd Quarter and First Half
    Navamedic Asa Reports Financials for 2nd Quarter and First Half

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa-financial-report-for-the-2nd-quarter-and-first-half-of-2025-302529842.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share
    Flexilev® in OraFID® Gets Approval in All Nordic Countries
    Flexilev® in OraFID® Gets Approval in All Nordic Countries

    13 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa-national-approvals-of-flexilev-in-orafid-granted-across-all-nordic-countries-302528798.html

    PR NEWSWIRE
    13 Aug 2025
    Share Share
    Navamedic ASA: Finalizes Acquisition of Dne Pharma Business
    Navamedic ASA: Finalizes Acquisition of Dne Pharma Business

    15 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa-closing-of-the-transaction-to-acquire-the-business-of-dne-pharma-302505463.html

    PR NEWSWIRE
    15 Jul 2025
    Share Share
    Navamedic ASA's Extraordinary General Meeting Minutes
    Navamedic ASA's Extraordinary General Meeting Minutes

    14 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa---minutes-of-extraordinary-general-meeting-302504335.html

    PR NEWSWIRE
    14 Jul 2025
    Share Share
    Navamedic : OraFid® Approved as Primary Package
    Navamedic : OraFid® Approved as Primary Package

    27 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/navamedic-asa-first-approval-of-the-medical-device-orafid-as-primary-package-for-a-pharmaceutical-product-302493246.html

    PR NEWSWIRE
    27 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search